Literature DB >> 23279873

Reproducibility of the WHO classification of thymomas: practical implications.

P A Zucali1, L Di Tommaso, I Petrini, S Battista, H S Lee, M Merino, E Lorenzi, E Voulaz, F De Vincenzo, M Simonelli, M Roncalli, L Giordano, M Alloisio, A Santoro, G Giaccone.   

Abstract

BACKGROUND: The WHO-classification was shown to be an independent prognostic marker in some but not all retrospective studies possibly due to lack of reproducibility. We investigated the reproducibility of the WHO-classification and its prognostic implication using a large series of resected thymomas.
METHODS: Four independent pathologists histologically classified a surgical series of 129 thymic tumors in a blinded fashion. Fleiss' kappa-coefficient was used to assess the pathologists' overall agreement, and Cohen-Kappa to assess the agreement between two observers. Disease-related-survival (DRS) and progression-free-survival (PFS) curves were generated by Kaplan-Meier method and compared by log-rank test.
RESULTS: In 63/129 (48.8%) cases there was a complete agreement; in 43/129 (33.3%) cases 3/4 pathological diagnoses were identical; in 15/129 (11.6%) cases the diagnoses were identical by pair; in 8/129 (6.2%) cases three different pathological diagnoses were on record. The Kappa-correlation coefficient was only moderate (0.53). A following web review carried out on the 23 cases with at least two different diagnoses reached a complete consensus. The histotype showed a statistically significant impact on PFS and DRS in the classification provided by only two pathologists.
CONCLUSIONS: In this study, the agreement on WHO classification of thymomas was only moderate and this impacted on patients management. Web consensus conference on the diagnosis, more stringent diagnostic criteria or the adoption of referral diagnostic centres may substantially reduce discrepancies. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23279873      PMCID: PMC3575111          DOI: 10.1016/j.lungcan.2012.11.015

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.

Authors:  Paolo A Zucali; Iacopo Petrini; Elena Lorenzi; Maria Merino; Liang Cao; Luca Di Tommaso; Hye Seung Lee; Matteo Incarbone; Beatriz A Walter; Matteo Simonelli; Massimo Roncalli; Armando Santoro; Giuseppe Giaccone
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

2.  Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors.

Authors:  Lara Chalabreysse; Pascal Roy; Jean-François Cordier; Robert Loire; Jean-Paul Gamondes; Françoise Thivolet-Bejui
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

3.  The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.

Authors:  Meinoshin Okumura; Mitsunori Ohta; Hisashi Tateyama; Katsuhiro Nakagawa; Akihide Matsumura; Hajime Maeda; Hiroto Tada; Tadaaki Eimoto; Hikaru Matsuda; Akira Masaoka
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

4.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

5.  New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.

Authors:  Gang Chen; Alexander Marx; Wen-Hu Chen; Jiang Yong; Bernhard Puppe; Philipp Stroebel; Hans Konrad Mueller-Hermelink
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

6.  Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification.

Authors:  Moo Suk Park; Kyung Young Chung; Kil Dong Kim; Woo Ick Yang; Jae Ho Chung; Young Sam Kim; Joon Chang; Joo Hang Kim; Sung Kyu Kim; Se Kyu Kim
Journal:  Ann Thorac Surg       Date:  2004-09       Impact factor: 4.330

7.  Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution.

Authors:  Shin-ichi Takeda; Shinichiro Miyoshi; Akinori Akashi; Mitsunori Ohta; Masato Minami; Meinoshin Okumura; Akira Masaoka; Hikaru Matsuda
Journal:  J Surg Oncol       Date:  2003-05       Impact factor: 3.454

8.  WHO histologic classification is a prognostic indicator in thymoma.

Authors:  Kazuya Kondo; Kiyoshi Yoshizawa; Masaru Tsuyuguchi; Suguru Kimura; Masayuki Sumitomo; Junji Morita; Takanori Miyoshi; Shoji Sakiyama; Kiyoshi Mukai; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

9.  Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases.

Authors:  J M Verley; K H Hollmann
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

10.  Long-term survival and prognostic factors in thymic epithelial tumours.

Authors:  Federico Rea; Giuseppe Marulli; Rodolfo Girardi; Luigi Bortolotti; Adolfo Favaretto; Alessandra Galligioni; Francesco Sartori
Journal:  Eur J Cardiothorac Surg       Date:  2004-08       Impact factor: 4.191

View more
  14 in total

1.  Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Authors:  Hyun-Sung Lee; Hee-Jin Jang; Rohan Shah; David Yoon; Masatsugu Hamaji; Ori Wald; Ju-Seog Lee; David J Sugarbaker; Bryan M Burt
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

2.  Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors.

Authors:  Fabio Conforti; Xu Zhang; Guanhua Rao; Tommaso De Pas; Yoko Yonemori; Jose Antonio Rodriguez; Justine N McCutcheon; Raneen Rahhal; Anna T Alberobello; Yisong Wang; Yu-Wen Zhang; Udayan Guha; Giuseppe Giaccone
Journal:  Cancer Res       Date:  2017-08-17       Impact factor: 12.701

3.  PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors.

Authors:  Anna Teresa Alberobello; Yisong Wang; Frans Joseph Beerkens; Fabio Conforti; Justine N McCutcheon; Guanhua Rao; Mark Raffeld; Jing Liu; Raneen Rahhal; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2016-04-24       Impact factor: 15.609

4.  A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.

Authors:  Iacopo Petrini; Paul S Meltzer; In-Kyu Kim; Marco Lucchi; Kang-Seo Park; Gabriella Fontanini; James Gao; Paolo A Zucali; Fiorella Calabrese; Adolfo Favaretto; Federico Rea; Jaime Rodriguez-Canales; Robert L Walker; Marbin Pineda; Yuelin J Zhu; Christopher Lau; Keith J Killian; Sven Bilke; Donna Voeller; Sivanesan Dakshanamurthy; Yisong Wang; Giuseppe Giaccone
Journal:  Nat Genet       Date:  2014-06-29       Impact factor: 38.330

5.  Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience.

Authors:  Kersti Oselin; Nicolas Girard; Katrin Lepik; Aidi Adamson-Raieste; Tõnu Vanakesa; Ingemar Almre; Tiina Leismann; Lara Chalabreysse
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

6.  Radical thymectomy versus conservative thymomectomy in the surgical treatment of thymic malignancies.

Authors:  Emanuele Voulaz; Giulia Veronesi; Maurizio Infante; Umberto Cariboni; Alberto Testori; Pierluigi Novellis; Edoardo Bottoni; Eliseo Passera; Emanuela Morenghi; Marco Alloisio
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 7.  Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapy.

Authors:  Yusuke Okuma; Makoto Saito; Yukio Hosomi; Toshikazu Sakuyama; Tatsuru Okamura
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-22       Impact factor: 4.553

8.  Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.

Authors:  Jean-Michel Maury; Claire Merveilleux du Vignaux; Gabrielle Drevet; Virginie Zarza; Lara Chalabreysse; Carine Maisse; Barbara Gineys; Christine Dolmazon; François Tronc; Nicolas Girard; Caroline Leroux
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

9.  Bioinformatics analysis of the key potential ceRNA biomarkers in human thymic epithelial tumors.

Authors:  Kegong Chen; Long Bai; Lin Ji; Libo Wu; Guanghua Li
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

10.  A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.

Authors:  Milan Radovich; Jeffrey P Solzak; Bradley A Hancock; Madison L Conces; Rutuja Atale; Ryan F Porter; Jin Zhu; Jarret Glasscock; Kenneth A Kesler; Sunil S Badve; Bryan P Schneider; Patrick J Loehrer
Journal:  Br J Cancer       Date:  2016-01-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.